Ruhter; Gerd

Patent Applications and Registrations

Patent applications and USPTO patent grants for Ruhter; Gerd.The latest application filed is for "4-aryl-n-phenyl-1,3,5-triazin-2-amines containing a sulfoximine group".

Company Profile

0.15.21

Ruhter; Gerd - Hamburg DE
Ruhter, Gerd - Vierzigstuecken Hamburg DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
4-aryl-N-phenyl-1,3,5-triazin-2-amines containing a sulfoximine group Grant 9,962,389 - Lucking , et al. May 8, 2	2018-05-08
4-aryl-n-phenyl-1,3,5-triazin-2-amines Containing A Sulfoximine Group App 20170217949 - LUCKING; Ulrich ; et al.	2017-08-03
4-aryl-N-phenyl-1,3,5-triazin-2-amines containing a sulfoximine group Grant 9,669,034 - Lucking , et al. June 6, 2	2017-06-06
Cyclosporin derivatives Grant 9,453,051 - Fischer , et al. September 27, 2	2016-09-27
Pharmaceutically active disubstituted pyridine derivatives Grant 9,242,937 - Ruhter , et al. January 26, 2	2016-01-26
Pharmaceutically active disubstituted triazine derivatives Grant 9,226,929 - Ruhter , et al. January 5, 2	2016-01-05
Pharmaceutically active pyrazolo-triazine derivatives Grant 9,096,608 - Eickhoff , et al. August 4, 2	2015-08-04
Pharmaceutically Active Pyrazolo-triazine Derivatives App 20150111873 - Eickhoff; Jan ; et al.	2015-04-23
Substituted 4-Aryl-N-phenyl-1,3,5-triazin-2-amines Grant 8,916,557 - Lucking , et al. December 23, 2	2014-12-23
4-aryl-n-phenyl-1,3,5-triazin-2-amines Containing A Sulfoximine Group App 20140315906 - Lucking; Ulrich ; et al.	2014-10-23
Cyclosporin Derivatives App 20140316104 - Fischer; Gunter ; et al.	2014-10-23
Pharmaceutically Active Disubstituted Pyridine Derivatives App 20140296304 - Ruhter; Gerd ; et al.	2014-10-02
Pharmaceutically Active Disubstituted Triazine Derivatives App 20140179662 - Ruhter; Gerd ; et al.	2014-06-26
Substituted 4-aryl-n-phenyl-1,3,5-triazin-2-amines App 20140045852 - Lucking; Ulrich ; et al.	2014-02-13
Pharmaceutically Active Disubstituted Triazine Derivatives App 20130079345 - Eickhoff; Jan ; et al.	2013-03-28
Methods for producing chiral chromones, chromanes, amino substituted chromanes and intermediates therefor Grant 6,756,403 - Briggs , et al. June 29, 2	2004-06-29
Methods for producing chiral chromones, chromanes, amino substituted chromanes and intermediates therefor App 20040053992 - Briggs, Barbara ; et al.	2004-03-18
Spiro compounds as inhibitors of fibrinogen-dependent platelet aggregation Grant 6,693,109 - Fisher , et al. February 17, 2	2004-02-17
Methods for producing amino-substituted chromanes App 20040014804 - Antoine, Luc ; et al.	2004-01-22
Method for resolving chiral (2s) and (2r) chromanes App 20040014994 - Antoine, Luc ; et al.	2004-01-22
Hypoglycemic imidazoline compounds App 20040009976 - Takeuchi, Kumiko ; et al.	2004-01-15
Spiro compounds as inhibitors of fibrinogen-dependent platelet aggregation App 20030171373 - Fisher, Matthew J. ; et al.	2003-09-11
Glycoprotein llb/llla antagonists App 20030130342 - Fisher, Matthew J. ; et al.	2003-07-10
Spiro compounds as inhibitors of fibrinogen-dependent platelet aggregation App 20020013325 - Fisher, Matthew J. ; et al.	2002-01-31
Protein kinase C inhibitors Grant 5,668,152 - Heath, Jr. , et al. September 16, 1	1997-09-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.